Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia by Abdulaali R. Almutairi PhD, Yazed Alruthia PhD, Majed S. Alyami PharmD, Omar A. Alshaya PharmD, Taif Z. Alanazi PharmD, Sarah I. Al Daghreer PharmD, Ghazwa B. Korayem PharmD, Sarah A. Alrasheed PharmD, Reema A. Alorf PharmD, Omar A. Almohammed PhD

Get full text

Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study by Majed S. Al Yami PharmD, Abdulmajeed M. Alshehri PharmD, Ghadah M. Alotaibi PharmD, Mariam S. Alsulimani PharmD, Fay M. Alotaibi PharmD, Rawan A. Alotaibi PharmD, Nouf A. Alqahtani PharmD, Lama A. Alhumaidan PharmD, Lubna S. Bin Hadhir PharmD, Norah M. Alebrah PharmD, Sumaya N. Almohareb PharmD, Omar A. Alshaya PharmD, Omar S. Alkhezi PharmD, Osamah M. Alfayez PharmD, Omar A. Almohammed PhD, Amal M. Badawoud PhD

Get full text